Illuminating the Life of GPCRs
Shining a Light on Psychiatric Disorders
Towards Fast Discovery of New Vaccines
Match-Making Peptides with Small Molecules
The Antibiotic Resistance Reservoir
Directing the Affinity of Monoclonal Antibodies
Opportunities for Pan-Spectrum Drugs against Herpes
Breathing Space: Biomarkers in Pulmonary Hypertension
Breakthrough Discovery in Diabetes
GPCR FlAsH-Walk Mapping: A Leap into the Future
Predicting the Unpredictable

A promising projects portfolio

As of today, CQDM has 35 outstanding research projects for a total of $ 33.3 M invested. These projects are carried out by a network of more than 460 researchers, including 85 graduate students, from 51 research institutions (28 public and 23 private) in Quebec, Canada and internationally. These projects cut across 100 mentors from CQDM’s pharmaceutical companies members.

completed projects